The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Bank of ...

4 Affitech Research AS XOMA Royalty paid $6 million in milestones to Affitech related to VABYSMO ® (faricimab ... related to the performance stock unit grant awarded to Mr. Hughes in connection ...

At the same time, the company announced a $700 million project to build a new pharmaceutical fill-and-finish plant for its Genentech unit near Raleigh ... eye medication Vabysmo for the Chinese ...

4 Affitech Research AS XOMA Royalty paid $6 million in milestones to Affitech related to VABYSMO ® (faricimab-svoa ... timing of expense recognition related to the performance stock unit grant awarded ...

Last week, the company announced a 2.04bn yuan ($282m) investment to build a new production site in Shanghai for its eye drug Vabysmo (faricimab). That facility is expected to be completed by 2029 and ...

Please note that Regeneron co-developed Eylea with the HealthCare unit of Bayer AG BAYRY ... for some time now due to competition from Vabysmo. We note that Vabysmo's uptake has been outstanding.

“Our growing commercial royalty portfolio of six assets is supported by VABYSMO® (faricimab), OJEMDA ... Bioscience's Biopharma Solutions business unit. Daré Bioscience XOMA Royalty ...

Vabysmo pre-filled syringe now also approved ... so there were more costs coming from other units into SG&A. Diabetes Care is one element that we integrated, just to mention example here, that's ...

Roche RHHBY announced that the European Medicines Agency has approved a prefilled syringe (PFS) of the ophthalmology drug Vabysmo (faricimab). The regulatory body approved Vabysmo PFS for use in ...

Vabysmo (faricimab-svoa) is a prescription drug that works to treat a type of macular degeneration and other eye conditions by blocking certain proteins in your body. Your response to this drug ...

Roche is relying on its portfolio of experimental medicines to kick-start growth through the end of this decade after a more than yearlong overhaul of its research and development units ... thanks to ...